Roche Holding AG (OTCMKTS:RHHBY) Short Interest Up 25.2% in October

Roche Holding AG (OTCMKTS:RHHBY) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 3,246,800 shares, an increase of 25.2% from the September 30th total of 2,593,100 shares. Based on an average daily trading volume, of 2,151,600 shares, the short-interest ratio is currently 1.5 days.

Roche Stock Down 1.0 %

Shares of RHHBY traded down $0.39 during mid-day trading on Wednesday, reaching $39.46. The company had a trading volume of 831,027 shares, compared to its average volume of 2,155,573. The firm has a fifty day simple moving average of $39.88 and a 200-day simple moving average of $36.48. Roche has a fifty-two week low of $29.20 and a fifty-two week high of $42.43.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on RHHBY shares. Bank of America raised Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Roche from a “hold” rating to a “sell” rating in a report on Friday, September 13th. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Roche currently has an average rating of “Hold”.

Institutional Trading of Roche

A number of institutional investors and hedge funds have recently bought and sold shares of the business. AlphaMark Advisors LLC bought a new stake in shares of Roche in the 1st quarter worth about $34,000. GAMMA Investing LLC lifted its stake in Roche by 61.5% during the second quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock valued at $175,000 after purchasing an additional 1,919 shares during the last quarter. Archer Investment Corp lifted its holdings in shares of Roche by 10.6% during the second quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock valued at $236,000 after purchasing an additional 652 shares during the last quarter. Waldron Private Wealth LLC acquired a new stake in shares of Roche during the second quarter valued at approximately $263,000. Finally, Lee Danner & Bass Inc. purchased a new position in Roche during the 2nd quarter worth approximately $327,000.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.